The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry.
XXXI International Congress of the International Academy of Pathology and 28th Congress of the European Society of Pathology, Köln, Almanya, 25 - 29 Eylül 2016